Susquehanna International Group, LLP Foghorn Therapeutics Inc. Call Options Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2023

Aug 11, 2023
BUY
$5.37 - $8.84 $161,637 - $266,084
30,100 New
30,100 $211,000
Q4 2022

Feb 14, 2023
SELL
$5.44 - $9.46 $5,984 - $10,406
-1,100 Reduced 2.97%
35,900 $229,000
Q3 2022

Nov 14, 2022
BUY
$7.52 - $18.01 $278,240 - $666,370
37,000 New
37,000 $317,000
Q4 2021

Feb 14, 2022
BUY
$10.79 - $22.87 $446,705 - $946,818
41,400 New
41,400 $947,000

Others Institutions Holding FHTX

# of Institutions
80
Shares Held
33.3M
Call Options Held
8.7K
Put Options Held
2.4K
View Full List

About Foghorn Therapeutics Inc.

FHTX Quotes by TradingView
  • Ticker FHTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,637,400
  • Market Cap $333M
  • Description
  • Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...
More about FHTX
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email